Search results for "metabolite"

showing 10 items of 551 documents

Synergistic platelet antiaggregatory effects of the adenylate cyclase activator iloprost and the guanylate cyclase activating agent SIN-1 in vivo

1993

The aim of our study was to evaluate the platelet antiaggregatory and hemodynamic effects of the stable prostacyclin analog iloprost and the NO-donor SIN-1, an active metabolite of molsidomine. The number of circulating platelets was determined in anesthetized male Wistar rats as a measure of in vivo platelet aggregation. Platelet count decreased from 648 +/- 25 to 476 +/- 15 x 10(3) platelets/microliter and from 578 +/- 36 to 411 +/- 40 (mean +/- SEM) in response to two repetitive injections of collagen (70 micrograms/kg body weight). Treatment with SIN-1 bolus injections (0.3 or 1 mg/kg bw) and/or continuous i.v. infusion of iloprost (0.2 or 0.4 micrograms/kg bw/min) was initiated 15 min …

Malemedicine.medical_specialtyMolsidominePlatelet AggregationPlatelet aggregationBlood PressureProstacyclinNitric Oxidechemistry.chemical_compoundIn vivoInternal medicinemedicineAnimalsPlateletIloprostRats WistarAntihypertensive AgentsActive metaboliteChemistryDrug SynergismHematologyRatsEnzyme ActivationEndocrinologyGuanylate CyclaseMolsidomineAdenylyl Cyclase InhibitorsPlatelet Aggregation InhibitorsSignal TransductionIloprostmedicine.drugGuanylate cyclaseThrombosis Research
researchProduct

Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a pha…

2008

Abstract Background This two-part phase Ib/II study investigated the feasibility of administering cetuximab in combination with oxaliplatin and infusional 5-fluorouracil (5-FU)/folinic acid (FA) in a weekly schedule (AIO FUFOX protocol) as first-line treatment in patients with epidermal growth factor receptor-detectable advanced colorectal cancer. Patients and methods Cetuximab was administered weekly: 400 mg/m2 initial dose, then 250 mg/m2 and FUFOX: oxaliplatin 50 mg/m2, FA 500 mg/m2 and 5-FU as a 24-h infusion at either 1500 or 2000 mg/m2 administered for 4 weeks followed by a 1-week rest (one cycle). Results Dose-limiting toxicity (grade 3 diarrhea) occurred in 3 of 14 assessable patien…

Malemedicine.medical_specialtyOrganoplatinum CompoundsColorectal cancermedicine.drug_classLeucovorinCetuximabAntibodies Monoclonal HumanizedGastroenterologyAntimetaboliteDisease-Free SurvivalFolinic acidPharmacokineticsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansAgedCetuximabDose-Response Relationship Drugbusiness.industryAntibodies MonoclonalHematologyMiddle Agedmedicine.diseaseOxaliplatinSurgeryIrinotecanErbB ReceptorsOxaliplatinOncologyFluorouracilPatient ComplianceFemaleFluorouracilbusinessColorectal Neoplasmsmedicine.drugAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Lipid peroxidation and nitric oxide metabolites in a group of subjects with obstructive sleep apnea syndrome.

2015

It is known that in OSAS the plasma lipid peroxidation has an opposite behavior in comparison with nitric oxide metabolites. In the re-examination of our survey of OSAS subjects we calculated the ratio between thiobarbituric acid reactive substances (TBARS) and nitric oxide metabolites (NOx) in relation to OSAS severity. The study has regarded 48 OSAS subjects subdivided in two subgroups according to the apnea/hypopnea index - AHI- (Low = 21 subjects with AHI30 and High = 27 subjects with AHI30). From the obtained data it is evident that the TBARS/NOx ratio is significantly higher in the H subgroup compared to L subgroup as well as this ratio is reduced in L subgroup in comparison with the …

Malemedicine.medical_specialtyPhysiologyThiobarbituric acidobstructive sleep apnea syndrome030204 cardiovascular system & hematologyNitric OxideNitric oxideLipid peroxidation03 medical and health scienceschemistry.chemical_compound0302 clinical medicinestomatognathic systemnitric oxide metabolitePhysiology (medical)Internal medicineTBARSLipid peroxidation; nitric oxide metabolites; obstructive sleep apnea syndrome; Female; Humans; Lipid Peroxidation; Male; Middle Aged; Nitric Oxide; Sleep Apnea Obstructive; Physiology; Hematology; Cardiology and Cardiovascular Medicine; Physiology (medical)MedicineHumansNOxSleep Apnea Obstructivebusiness.industryApneaHematologyMiddle Agedmedicine.diseasenervous system diseasesrespiratory tract diseasesObstructive sleep apneaEndocrinology030228 respiratory systemchemistryFemaleLipid Peroxidationmedicine.symptomCardiology and Cardiovascular MedicinebusinessHypopneaHumanClinical hemorheology and microcirculation
researchProduct

Endocannabinoid Levels in Newborns in Relation to the Mode of Delivery.

2015

Objective  This study aims to examine the endocannabinoid levels in newborns in relation to the mode of delivery. Study Design  In this study, the concentrations of the endocannabinoids anandamide (AEA), 2-arachidonylglycerol (2-AG), palmitoylethanolamine (PEA), and the metabolite arachidonic acid (AA) in umbilical cord vein blood of 49 newborns was determined by quantitative mass spectrometry using liquid chromatography multiple reaction monitoring. The newborns were divided by their mode of delivery. Only healthy newborns born after 34 0/7 gestational weeks without birth complications were included. Results  The concentration of AEA, PEA, and AA was significantly higher in vaginal deliver…

Malemedicine.medical_specialtyPolyunsaturated AlkamidesMetaboliteArachidonic AcidsMass SpectrometryGlycerideschemistry.chemical_compoundInternal medicineMedicineEndocrine systemHumansFetusbusiness.industryVaginal deliveryInfant NewbornObstetrics and GynecologyAnandamideDelivery ObstetricEndocannabinoid systemMode of deliveryEndocrinologychemistryAnesthesiaPediatrics Perinatology and Child Healthlipids (amino acids peptides and proteins)Arachidonic acidFemalebusinessChromatography LiquidEndocannabinoidsAmerican journal of perinatology
researchProduct

The Importance of Lipidomic Approach for Mapping and Exploring the Molecular Networks Underlying Physical Exercise: A Systematic Review

2021

Maintaining appropriate levels of physical exercise is an optimal way for keeping a good state of health. At the same time, optimal exercise performance necessitates an integrated organ system response. In this respect, physical exercise has numerous repercussions on metabolism and function of different organs and tissues by enhancing whole-body metabolic homeostasis in response to different exercise-related adaptations. Specifically, both prolonged and intensive physical exercise produce vast changes in multiple and different lipid-related metabolites. Lipidomic technologies allow these changes and adaptations to be clarified, by using a biological system approach they provide scientific u…

Malemedicine.medical_specialtyScoring systemQH301-705.5MEDLINEbiological systemsPhysical exerciseReviewCochrane LibraryCatalysisInorganic ChemistryPhysical medicine and rehabilitationExercise performanceLipidomicsmedicineMetabolomeHumansPhysical and Theoretical ChemistryBiology (General)Muscle SkeletalMolecular BiologyExerciseQD1-999Spectroscopymetabolitestrainingbiological systems; training; lipid profile; sports; metabolitesOrganic ChemistryGeneral MedicineComputer Science ApplicationsMolecular networkChemistrylipid profileOrgan SpecificityLipidomicsFemalesportsBlood Chemical Analysis
researchProduct

Cholinergic modulation of the release of 5-hydroxytryptamine from the guinea pig ileum.

1987

Isolated segments of the guinea pig ileum were vascularly perfused and the release of 5-HT and its metabolite 5-HIAA into the portal venous effluent determined by HPLC with electrochemical detection. Test substances were applied via the arterial perfusion medium. Oxotremorine inhibited concentration-dependently the release of 5-HT and 5-HIAA (by 47% at 1 mumol/l). Scopolamine (0.1 mumol/l) did not affect the release of 5-HT and 5-HIAA, but antagonized the effect of oxotremorine. In the presence of TTX (1 mumol/l), oxotremorine (1 mumol/l) increased the release of 5-HT by 150% and that of 5-HIAA by 220%. This increase was completely blocked by scopolamine. Hexamethonium (100 mumol/l) and TTX…

Malemedicine.medical_specialtySerotoninMetaboliteGuinea PigsScopolamineHexamethonium CompoundsBiologyIn Vitro TechniquesReceptors NicotinicHexamethoniumGuinea pigchemistry.chemical_compoundIleumInternal medicineMuscarinic acetylcholine receptorOxotremorinemedicineEnterochromaffin CellsAnimalsReceptors CholinergicIntestinal MucosaPharmacologyMuscarineOxotremorineGeneral MedicineEndocrinologynervous systemchemistryEnterochromaffin cellHexamethoniumSerotoninmedicine.drugNaunyn-Schmiedeberg's archives of pharmacology
researchProduct

Effect of vasoactive intestinal polypeptide on the release of serotonin from the in vitro vascularly perfused small intestine of guinea pig.

1989

Isolated segments of the guinea pig small intestine were vascularly perfused and the release of endogenous serotonin (5-HT) and its metabolite 5-hydroxyindoleacetic acid (5-HIAA) into the portal vein was measured. All test substances were intraarterially perfused. Vasoactive intestinal polypeptide (VIP, 1 pmol/l-100 nmol/l) inhibited the spontaneous release of 5-HT and 5-HIAA. The maximal inhibitory effect (about 60%) was seen at 100 pmol/l. The effect of VIP on the spontaneous release of 5-HT and 5-HIAA was not changed in the presence of 1 mumol/l tetrodotoxin (TTX). Raising intraluminal pressure by 500 Pa for 5 min increased the release of 5-HT and 5-HIAA by about 25%. Raising the intralu…

Malemedicine.medical_specialtySerotoninMetaboliteVasoactive intestinal peptideGuinea PigsTetrodotoxinBiologyIn Vitro TechniquesGuinea pigchemistry.chemical_compoundInternal medicineIntestine SmallmedicineAnimalsPharmacologyMuscle SmoothGeneral MedicineHydroxyindoleacetic AcidSmall intestineEndocrinologymedicine.anatomical_structurenervous systemGastrointestinal hormonechemistryEnterochromaffin cellTetrodotoxinSerotoninhormones hormone substitutes and hormone antagonistsMuscle ContractionVasoactive Intestinal PeptideNaunyn-Schmiedeberg's archives of pharmacology
researchProduct

Seasonal variation in total phenolic content of Dictyopteris polypodioides (Dictyotaceae) and Cystoseira amentacea (Sargassaceae) from the Sicilian c…

2013

Phlorotannins are polyphenolic secondary metabolites found in almost all brown algae that function as defense against grazers, pathogens and epiphytes but are also involved in photoprotection mechanisms. These compounds, produced in the Golgi apparatus, are accumulated in cytoplasm, within vesicules called physodes, or bound to the cell wall. The concentration of phlorotannins dif-fers within and between species, shows geographical variations but may be also affected by abiotic or biotic factors. Aims of this study were to evaluate: (i) the temporal variation of total phenolic content in two brown algae, Dictyopteris polypodioides and Cystoseira amentacea, living respec-tively in the upper …

Mar MediterraneoSettore BIO/02 - Botanica SistematicaBrown algaeSettore BIO/04 - Fisiologia Vegetalesecondary metabolitephenol compound
researchProduct

One-Year Changes in Urinary Microbial Phenolic Metabolites and the Risk of Type 2 Diabetes—A Case-Control Study

2022

The intake of polyphenols has been associated with a risk reduction of type 2 diabetes. Nevertheless, to the best of our knowledge, the molecules that might be metabolically active after ingestion are only starting to be investigated regarding this metabolic disease. To investigate the association between one-year changes in urinary microbial phenolic metabolites (MPM) and the incidence of type 2 diabetes, we performed a case-control study using data and samples of the PREDIMED trial including 46 incident type 2 diabetes cases of 172 randomly selected participants. Eight urinary MPMs were quantified in urine by liquid chromatography coupled to mass spectrometry and used to assess their asso…

Mass spectrometryPhysiologyClinical BiochemistryPhytochemicalsLiquid chromatographyPREDIMED studyCell BiologyCardiovascularCromatografia de líquidsBiochemistrySustancias fitoquímicasbioactive compounds; phytochemicals; Mediterranean diet; PREDIMED study; urinary microbial phenolic metabolites; cardiovascular; liquid chromatography; mass spectrometryBioactive compoundsUrinary microbial phenolic metabolitesEspectrometria de massesMediterranean dietCompostos bioactiusMolecular Biology
researchProduct

Immobilization and controlled release of prostaglandin E2 from poly-L-lactide-co-glycolide microspheres.

2009

Prostaglandin E(2) (PGE(2)) is an arachidonic acid metabolite involved in physiological homeostasis and numerous pathophysiological conditions. Furthermore, it has been demonstrated that prostaglandins have a stimulating effect not only on angiogenesis in situ and in vitro but also on chondrocyte proliferation in vitro. Thus, PGE(2) represents an interesting signaling molecule for various tissue engineering strategies. However, under physiological conditions, PGE(2) has a half-life time of only 10 min, which limits its use in biomedical applications. In the present study, we investigated if the incorporation of PGE(2) into biodegradable poly-L-lactide-co-glycolide microspheres results in a …

Materials scienceMetabolitemedicine.medical_treatmentKineticsBiomedical EngineeringProstaglandinDinoprostoneBiomaterialschemistry.chemical_compoundmedicineProstaglandin E2Particle SizePolyglactin 910ChromatographyMetals and AlloysControlled releaseIn vitroMicrospheresKineticschemistryBiochemistryDelayed-Action PreparationsCeramics and Compositeslipids (amino acids peptides and proteins)Arachidonic acidProstaglandin Emedicine.drugJournal of biomedical materials research. Part A
researchProduct